Development of new therapeutic strategies for Parkinson's disease based on replacement of L-DOPA using rAAV vectors

被引:0
|
作者
Kirik, D. [1 ]
机构
[1] Lund Univ, Dept Expt Med Sci, Sect Neurosci, CNS Dis Modeling Unit, Lund, Sweden
关键词
D O I
暂无
中图分类号
Q813 [细胞工程];
学科分类号
摘要
引用
收藏
页码:561 / 561
页数:1
相关论文
共 50 条
  • [1] Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors
    Carlsson, T
    Winkler, C
    Burger, C
    Muzyczka, N
    Mandel, RJ
    Cenci, A
    Björklund, A
    Kirik, D
    BRAIN, 2005, 128 : 559 - 569
  • [2] Parkinson’s Disease: New Therapeutic Developments from L-DOPA to Digital Therapies
    Francesco Ferrara
    SN Comprehensive Clinical Medicine, 7 (1)
  • [3] L-dopa response in Parkinson's disease - A study with L-dopa infusion test
    Saiki, H.
    Matsumoto, S.
    MOVEMENT DISORDERS, 2012, 27 : S50 - S50
  • [4] L-dopa related hyperhomocysteinemia and development of dementia in Parkinson's disease
    dell'Aquila, C.
    Zoccolella, S.
    Mascolo, L.
    Abruzzese, G.
    Antonini, A.
    Bonuccelli, U.
    Dlazio, G.
    Pacchetti, C.
    Lamberti, P.
    MOVEMENT DISORDERS, 2008, 23 (01) : S249 - S249
  • [5] Peculiarities of L-DOPA treatment of Parkinson’s disease
    R. M. Kostrzewa
    P. Nowak
    J. P. Kostrzewa
    R. A. Kostrzewa
    R. Brus
    Amino Acids, 2005, 28 : 157 - 164
  • [6] Monitoring of L-dopa concentrations in Parkinson's disease
    Furlanut, M
    Furlanut, M
    Benetello, P
    PHARMACOLOGICAL RESEARCH, 2001, 43 (05) : 423 - 427
  • [7] L-dopa induced dyskinesia in Parkinson's disease
    Bastide, Matthieu F.
    Bezard, Erwan
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2015, 199 (2-3): : 201 - 212
  • [8] Focusing Effects of L-Dopa in Parkinson's Disease
    Ng, Bernard
    Palmer, Samantha
    Abugharbieh, Rafeef
    McKeown, Martin J.
    HUMAN BRAIN MAPPING, 2010, 31 (01) : 88 - 97
  • [9] The effect of L-dopa on speech in Parkinson's disease
    Skodda, S.
    Schlegel, U.
    JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (02) : 233 - 233
  • [10] Peculiarities of L-DOPA treatment of Parkinson's disease
    Kostrzewa, RM
    Nowak, P
    Kostrzewa, JP
    Kostrzewa, RA
    Brus, R
    AMINO ACIDS, 2005, 28 (02) : 157 - 164